Arana GW. Overview of side effects caused by typical anti-psychotics. J Clin Psychiatry. 2000;61:5–11.Google Scholar
Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol. 2001;6:153–62.Google Scholar
Usher K, Foster K, Park T. The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management. J Psychiatr Ment Health Nurs. 2006;13:730–4.PubMedCrossrefGoogle Scholar
Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H. Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol. 1996;6:13–20.CrossrefGoogle Scholar
McEvoy JP, McCue M, Spring B, Mohs RC, Lavori PW, Farr RM. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers. Am J Psychiatry. 1987;144:573–7.PubMedCrossrefGoogle Scholar
Minzenberg MJ, Poole JH, Benton C, Vinogradov S. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry. 2004;161:116–24.CrossrefPubMedGoogle Scholar
Vancampfort D, Vansteelandt K, Scheewe T, Probst M, Knapen J, De Herdt A, et al. Yoga in schizophrenia: a systematic review of randomised controlled trials. Acta Psychiatr Scand. 2012;126:12–20.CrossrefWeb of SciencePubMedGoogle Scholar
Duraiswamy G, Thirthalli J, Nagendra HR, Gangadhar BN. Yoga therapy as an add‐on treatment in the management of patients with schizophrenia – a randomized controlled trial. Acta Psychiatr Scand. 2007;116:226–32.Web of ScienceCrossrefPubMedGoogle Scholar
Varambally S, Gangadhar BN, Thirthalli J, Jagannathan A, Kumar S, Venkatasubramanian G, et al. Therapeutic efficacy of add-on yogasana intervention in stabilized outpatient schizophrenia: randomized controlled comparison with exercise and waitlist. Indian J Psychiatry. 2012;54:227.CrossrefPubMedGoogle Scholar
Manjunath RB, Varambally S, Thirthalli J, Basavaraddi IV, Gangadhar BN. Efficacy of yoga as an add-on treatment for in-patients with functional psychotic disorder. Indian J Psychiatry. 2013;55:374.CrossrefWeb of ScienceGoogle Scholar
Visceglia E, Lewis S. Yoga therapy as an adjunctive treatment for schizophrenia: a randomized, controlled pilot study. J Altern Complement Med. 2011;17:601–7.CrossrefWeb of SciencePubMedGoogle Scholar
Thirthalli J, Duraiswamy G, Varambally S, Nagendra HR, Gangadhar BN. Yoga as an add-on treatment in the management of schizophrenia: a randomized controlled trial. Ann Gen Psychiatry. 2006;5:84.CrossrefGoogle Scholar
Jayaram N, Varambally S, Behere RV, Venkatasubramanian G, Arasappa R, Christopher R, et al. Effect of yoga therapy on plasma oxytocin and facial emotion recognition deficits in patients of schizophrenia. Indian J Psychiatry. 2013 Jul;55:S409.CrossrefWeb of ScienceGoogle Scholar
Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract. 2005;18:491–519.CrossrefGoogle Scholar
Ikai S, Uchida H, Suzuki T, Tsunoda K, Mimura M, Fujii Y. Effects of yoga therapy on postural stability in patients with schizophrenia-spectrum disorders: a single-blind randomized controlled trial. J Psychiatr Res. 2013;47:1744–50.Web of ScienceCrossrefPubMedGoogle Scholar
Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients. Acta Psychiatr Scand. 1987;76:1–00.CrossrefGoogle Scholar
Zalonis I, Kararizou E, Triantafyllou NI, Kapaki E, Papageorgiou S, Sgouropoulos PE, et al. A normative study of the trail making test A and B in Greek adults. Clin Neuropsychol. 2008 Sep 1;22:842–50.CrossrefWeb of ScienceGoogle Scholar
Norman RM, Malla AK, Cortese L, Diaz F. A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophr Res. 1996 Mar 31;19:73–85.CrossrefPubMedGoogle Scholar
Govindaraj R, Varambally S, Sharma M, Gangadhar BN. Designing and validation of a yoga-based intervention for schizophrenia. Int Rev Psychiatry. 2016;28:323–6.CrossrefWeb of SciencePubMedGoogle Scholar
Bhatia T, Agarwal A, Shah G, Wood J, Richard J, Gur RE, et al. Adjunctive cognitive remediation for schizophrenia using yoga: an open, non‐randomised trial. Acta Neuropsychiatr. 2012;24:91–100.Web of ScienceCrossrefGoogle Scholar
Bhargav H, Nagendra HR, Gangadhar BN, Nagarathna R. Frontal hemodynamic responses to high frequency yoga breathing in schizophrenia: a functional near-infrared spectroscopy study. Front Psychiatry. 2014;5:29PubMedWeb of ScienceGoogle Scholar
Streeter CC, Gerbarg PL, Saper RB, Ciraulo DA, Brown RP. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 2012;78:571–9.PubMedCrossrefWeb of ScienceGoogle Scholar
Naveen GH, Thirthalli J, Rao MG, Varambally S, Christopher R, Gangadhar BN. Positive therapeutic and neurotropic effects of yoga in depression: a comparative study. Indian J Psychiatry. 2013;55:S400.Web of ScienceCrossrefGoogle Scholar
About the article
Published Online: 2018-06-26
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.